clinical trial · NCT06925685
Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
Hematologic MalignanciesSolid Tumors
brief summary
An observational, long-term follow up (LTFU) study of participants who received an allogeneic CAR T product in a prior clinical study. Participants will be followed for 15 years after their last infusion of an allogenic CAR T cell product.
started
Jan 31, 2025
primary completion
Jan 1, 2039
completion
Jan 1, 2039
last updated
Apr 13, 2025
official title
Long Term Follow up Study for Participants Treated With an Allogeneic CAR T-Cell Product in a Prior Clinical Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol